Tirofiban a Better Option for Ischemic Stroke When Lytics and Thrombectomy Aren't?

TREND trial compares acute antiplatelet monotherapies

Related Keywords

Xuanwu ,Henan ,China ,Beijing ,United States ,Phoenix ,Arizona ,Chinese ,American ,Larryb Goldstein ,Wenbo Zhao ,American Stroke Association International Conference ,International Stroke Conference ,Xuanwu Hospital At Capital Medical University ,University Of Kentucky ,Xuanwu Hospital ,Capital Medical University ,American Stroke Association ,International Stroke ,New England Journal ,Rankin Scale ,